The red biotechnology market is on a steep growth trajectory, with the market size valued at USD 634 billion in 2024 and projected to reach a staggering USD 1423.51 billion by 2032, growing at a CAGR of 10.66% during the forecast period of 2025–2032. This phenomenal growth is fueled by advances in personalized medicine, biologics, and gene-based therapies, as well as increased government...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Greek